Clinical Trial Update: Efficacy and Tolerance of High Flow Nasal Cannula for Respiratory Distress Syndrom in Late Preterms (34-36 Weeks) [NA]

View source ↗

Summary

This completed trial assessed the efficacy and tolerability of high flow nasal cannula therapy for respiratory distress syndrome in late preterm infants (34-36 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Respiratory Distress Syndrom, High Flow Nasal Cannula | NA | Status: COMPLETED